Genmab | GEN - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Almirall EUR 429.87M 180.02M 2025-12
Amarin USD 23.17M 961K 2025-12
Amgen USD 5.87B 1.02B 2026-03
argenx SE USD 1.18B 40.98M 2026-03
AstraZeneca USD 12.86B 251M 2026-06
Bayer EUR 6.33B 1.84B 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Demant DKK 9.96B 1.13B 2026-06
Exelixis USD 608.03M 17.17M 2026-06
Fresenius Medical Care EUR 1.31B 130.98M 2026-06
Genmab DKK 1.07B 240M 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
GN Store Nord DKK 1.13B 116M 2026-06
GRIFOLS EUR 704M 84M 2026-06
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Insmed USD 356.19M 99.73M 2026-06
Lakefront Biotherapeutics EUR 1.68M 898.68M 2026-03
Lonza CHF 1.29B 248M 2025-06
Merck EUR 3.17B 101M 2026-06
Novartis USD 11.24B 1.18B 2026-06
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.71B 602M 2026-06
UCB EUR 3.19B 621M 2025-12